Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long Term Open-Label Extension Study Of Lersivirine For The Treatment Of HIV-1 Infection

NCT01254656 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01254656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01254656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long Term Open-Label Extension Study Of Lersivirine For The Treatment Of HIV-1 Infection
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2011
Completion date
April 30, 2013
Enrollment
108 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1